Cargando…

Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy

OBJECTIVE: The influence of diabetes on cardiac resynchronization therapy (CRT) remains unclear. The aims of the current study were to 1) assess the changes in left ventricular (LV) systolic and diastolic function and 2) evaluate long-term prognosis in CRT recipients with diabetes. RESEARCH DESIGN A...

Descripción completa

Detalles Bibliográficos
Autores principales: Höke, Ulas, Thijssen, Joep, van Bommel, Rutger J., van Erven, Lieselot, van der Velde, Enno T., Holman, Eduard R., Schalij, Martin J., Bax, Jeroen J., Delgado, Victoria, Marsan, Nina Ajmone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609501/
https://www.ncbi.nlm.nih.gov/pubmed/23223348
http://dx.doi.org/10.2337/dc12-1116
_version_ 1782264321741422592
author Höke, Ulas
Thijssen, Joep
van Bommel, Rutger J.
van Erven, Lieselot
van der Velde, Enno T.
Holman, Eduard R.
Schalij, Martin J.
Bax, Jeroen J.
Delgado, Victoria
Marsan, Nina Ajmone
author_facet Höke, Ulas
Thijssen, Joep
van Bommel, Rutger J.
van Erven, Lieselot
van der Velde, Enno T.
Holman, Eduard R.
Schalij, Martin J.
Bax, Jeroen J.
Delgado, Victoria
Marsan, Nina Ajmone
author_sort Höke, Ulas
collection PubMed
description OBJECTIVE: The influence of diabetes on cardiac resynchronization therapy (CRT) remains unclear. The aims of the current study were to 1) assess the changes in left ventricular (LV) systolic and diastolic function and 2) evaluate long-term prognosis in CRT recipients with diabetes. RESEARCH DESIGN AND METHODS: A total of 710 CRT recipients (171 with diabetes) were included from an ongoing registry. Echocardiographic evaluation, including LV systolic and diastolic function assessment, was performed at baseline and 6-month follow-up. Response to CRT was defined as a reduction of ≥15% in LV end-systolic volume (LVESV) at the 6-month follow-up. During long-term follow-up (median = 38 months), all-cause mortality (primary end point) and cardiac death or heart failure hospitalization (secondary end point) were recorded. RESULTS: At the 6-month follow-up, significant LV reverse remodeling was observed both in diabetic and non-diabetic patients. However, the response to CRT occurred more frequently in non-diabetic patients than in diabetic patients (57 vs. 45%, P < 0.05). Furthermore, a significant improvement in LV diastolic function was observed both in diabetic and non-diabetic patients, but was more pronounced in non-diabetic patients. The determinants of the response to CRT among diabetic patients were LV dyssynchrony, ischemic cardiomyopathy, and insulin use. Both primary and secondary end points were more frequent in diabetic patients (P < 0.001). Particularly, diabetes was independently associated with all-cause mortality together with ischemic cardiomyopathy, renal function, LVESV, LV dyssynchrony, and LV diastolic dysfunction. CONCLUSIONS: Heart failure patients with diabetes exhibit significant improvements in LV systolic and diastolic function after CRT, although they are less pronounced than in non-diabetic patients. Diabetes was independently associated with all-cause mortality.
format Online
Article
Text
id pubmed-3609501
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36095012014-04-01 Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy Höke, Ulas Thijssen, Joep van Bommel, Rutger J. van Erven, Lieselot van der Velde, Enno T. Holman, Eduard R. Schalij, Martin J. Bax, Jeroen J. Delgado, Victoria Marsan, Nina Ajmone Diabetes Care Original Research OBJECTIVE: The influence of diabetes on cardiac resynchronization therapy (CRT) remains unclear. The aims of the current study were to 1) assess the changes in left ventricular (LV) systolic and diastolic function and 2) evaluate long-term prognosis in CRT recipients with diabetes. RESEARCH DESIGN AND METHODS: A total of 710 CRT recipients (171 with diabetes) were included from an ongoing registry. Echocardiographic evaluation, including LV systolic and diastolic function assessment, was performed at baseline and 6-month follow-up. Response to CRT was defined as a reduction of ≥15% in LV end-systolic volume (LVESV) at the 6-month follow-up. During long-term follow-up (median = 38 months), all-cause mortality (primary end point) and cardiac death or heart failure hospitalization (secondary end point) were recorded. RESULTS: At the 6-month follow-up, significant LV reverse remodeling was observed both in diabetic and non-diabetic patients. However, the response to CRT occurred more frequently in non-diabetic patients than in diabetic patients (57 vs. 45%, P < 0.05). Furthermore, a significant improvement in LV diastolic function was observed both in diabetic and non-diabetic patients, but was more pronounced in non-diabetic patients. The determinants of the response to CRT among diabetic patients were LV dyssynchrony, ischemic cardiomyopathy, and insulin use. Both primary and secondary end points were more frequent in diabetic patients (P < 0.001). Particularly, diabetes was independently associated with all-cause mortality together with ischemic cardiomyopathy, renal function, LVESV, LV dyssynchrony, and LV diastolic dysfunction. CONCLUSIONS: Heart failure patients with diabetes exhibit significant improvements in LV systolic and diastolic function after CRT, although they are less pronounced than in non-diabetic patients. Diabetes was independently associated with all-cause mortality. American Diabetes Association 2013-04 2013-03-14 /pmc/articles/PMC3609501/ /pubmed/23223348 http://dx.doi.org/10.2337/dc12-1116 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Höke, Ulas
Thijssen, Joep
van Bommel, Rutger J.
van Erven, Lieselot
van der Velde, Enno T.
Holman, Eduard R.
Schalij, Martin J.
Bax, Jeroen J.
Delgado, Victoria
Marsan, Nina Ajmone
Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy
title Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy
title_full Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy
title_fullStr Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy
title_full_unstemmed Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy
title_short Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy
title_sort influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609501/
https://www.ncbi.nlm.nih.gov/pubmed/23223348
http://dx.doi.org/10.2337/dc12-1116
work_keys_str_mv AT hokeulas influenceofdiabetesonleftventricularsystolicanddiastolicfunctionandonlongtermoutcomeaftercardiacresynchronizationtherapy
AT thijssenjoep influenceofdiabetesonleftventricularsystolicanddiastolicfunctionandonlongtermoutcomeaftercardiacresynchronizationtherapy
AT vanbommelrutgerj influenceofdiabetesonleftventricularsystolicanddiastolicfunctionandonlongtermoutcomeaftercardiacresynchronizationtherapy
AT vanervenlieselot influenceofdiabetesonleftventricularsystolicanddiastolicfunctionandonlongtermoutcomeaftercardiacresynchronizationtherapy
AT vanderveldeennot influenceofdiabetesonleftventricularsystolicanddiastolicfunctionandonlongtermoutcomeaftercardiacresynchronizationtherapy
AT holmaneduardr influenceofdiabetesonleftventricularsystolicanddiastolicfunctionandonlongtermoutcomeaftercardiacresynchronizationtherapy
AT schalijmartinj influenceofdiabetesonleftventricularsystolicanddiastolicfunctionandonlongtermoutcomeaftercardiacresynchronizationtherapy
AT baxjeroenj influenceofdiabetesonleftventricularsystolicanddiastolicfunctionandonlongtermoutcomeaftercardiacresynchronizationtherapy
AT delgadovictoria influenceofdiabetesonleftventricularsystolicanddiastolicfunctionandonlongtermoutcomeaftercardiacresynchronizationtherapy
AT marsanninaajmone influenceofdiabetesonleftventricularsystolicanddiastolicfunctionandonlongtermoutcomeaftercardiacresynchronizationtherapy